Farrell E Cooke1, Jon D Samuels1, Alfons Pomp2, Farida Gadalla1, Xian Wu3, Cheguevara Afaneh2, Gregory F Dakin2, Peter A Goldstein4,5. 1. Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, Room A-1050, New York, NY, 10065, USA. 2. Department of Surgery, Weill Cornell Medical College, New York, NY, USA. 3. Department of Healthcare Policy and Research (Division of Biostatistics and Epidemiology), Weill Cornell Medical College, New York, NY, USA. 4. Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, Room A-1050, New York, NY, 10065, USA. pag2014@med.cornell.edu. 5. Department of Medicine, Weill Cornell Medical College, New York, NY, USA. pag2014@med.cornell.edu.
Abstract
BACKGROUND: Retrospective studies indicate that acetaminophen iv administration reduces hospital length of stay (LoS) and opiate consumption in patients undergoing bariatric surgery. OBJECTIVE: This study sought to determine whether using acetaminophen iv in morbidly obese subjects undergoing sleeve gastrectomy decreased LoS and total hospital charges as compared to patients receiving saline placebo. SETTING: Single-center university hospital METHODS: Using a randomized, double-blind, placebo-controlled design, subjects were assigned to receive either acetaminophen iv (group A) or saline placebo iv (group P). Data were collected between Jan 1 and Dec 31, 2016. Group A received acetaminophen every 6 h for a total of four doses. The first dose was administered following the induction of general anesthesia; group P received saline iv on the same schedule. Anesthetic management and prophylactic antiemetic regimen were standardized in all subjects. Postoperative pain management consisted of hydromorphone via patient-controlled infusion pump. Primary outcomes include hospital LoS and associated hospital costs. Secondary outcomes include patient satisfaction and postoperative nausea and pain scores. RESULTS: Subject demographics (n = 127) and intraoperative management were similar in the two groups. Across all subjects, median hospital LoS in group A (n = 63) was 1.87 vs. 1.97 days in group P (n = 64) (p = 0.03, Wilcoxon rank-sum test). Postoperatively, daily quality-of-recovery (QoR-15) scores, narcotic consumption, and the use of rescue antiemetics were not significantly different between groups. Median hospital costs were as follows: group A, $12,885 vs. group P, $12,977 (n = 64). CONCLUSIONS:Acetaminophen iv may reduce hospital LoS in subjects undergoing sleeve gastrectomy.
RCT Entities:
BACKGROUND: Retrospective studies indicate that acetaminophen iv administration reduces hospital length of stay (LoS) and opiate consumption in patients undergoing bariatric surgery. OBJECTIVE: This study sought to determine whether using acetaminophen iv in morbidly obese subjects undergoing sleeve gastrectomy decreased LoS and total hospital charges as compared to patients receiving saline placebo. SETTING: Single-center university hospital METHODS: Using a randomized, double-blind, placebo-controlled design, subjects were assigned to receive either acetaminophen iv (group A) or saline placebo iv (group P). Data were collected between Jan 1 and Dec 31, 2016. Group A received acetaminophen every 6 h for a total of four doses. The first dose was administered following the induction of general anesthesia; group P received saline iv on the same schedule. Anesthetic management and prophylactic antiemetic regimen were standardized in all subjects. Postoperative pain management consisted of hydromorphone via patient-controlled infusion pump. Primary outcomes include hospital LoS and associated hospital costs. Secondary outcomes include patient satisfaction and postoperative nausea and pain scores. RESULTS: Subject demographics (n = 127) and intraoperative management were similar in the two groups. Across all subjects, median hospital LoS in group A (n = 63) was 1.87 vs. 1.97 days in group P (n = 64) (p = 0.03, Wilcoxon rank-sum test). Postoperatively, daily quality-of-recovery (QoR-15) scores, narcotic consumption, and the use of rescue antiemetics were not significantly different between groups. Median hospital costs were as follows: group A, $12,885 vs. group P, $12,977 (n = 64). CONCLUSIONS:Acetaminophen iv may reduce hospital LoS in subjects undergoing sleeve gastrectomy.
Authors: Zhamak Khorgami; Ali Aminian; Saeed Shoar; Amin Andalib; Alan A Saber; Philip R Schauer; Stacy A Brethauer; Guido M Sclabas Journal: Surg Obes Relat Dis Date: 2017-04-15 Impact factor: 4.734
Authors: David E Arterburn; Maren K Olsen; Valerie A Smith; Edward H Livingston; Lynn Van Scoyoc; William S Yancy; George Eid; Hollis Weidenbacher; Matthew L Maciejewski Journal: JAMA Date: 2015-01-06 Impact factor: 56.272
Authors: E Eve Shaffer; An Pham; Robert L Woldman; Andrew Spiegelman; Scott A Strassels; George J Wan; Thomas Zimmerman Journal: Adv Ther Date: 2016-11-09 Impact factor: 3.845
Authors: Hoani Macfater; Weisi Xia; Sanket Srinivasa; Andrew Graham Hill; Marc Van De Velde; Girsh P Joshi Journal: World J Surg Date: 2019-06 Impact factor: 3.352
Authors: Yung Lee; James Yu; Aristithes G Doumouras; Vahid Ashoorion; Scott Gmora; Mehran Anvari; Dennis Hong Journal: Obes Surg Date: 2019-04 Impact factor: 4.129
Authors: Yoji Ogura; Jeffrey L Gum; Portia Steele; Charles H Crawford; Mladen Djurasovic; R Kirk Owens; Joseph L Laratta; Eric Davis; Morgan Brown; Christy Daniels; John R Dimar; Steven D Glassman; Leah Y Carreon Journal: J Spine Surg Date: 2020-12
Authors: Vinicius Barros Duarte de Morais; Rioko Kimiko Sakata; Ana Paula Santana Huang; Leonardo Henrique da Cunha Ferraro Journal: Acta Cir Bras Date: 2020-06-05 Impact factor: 1.388